WATCH: DCI Oncologists Discuss AML Therapies


In this Medscape video, hematologist-oncologists Harry Erba, MD, PhD, David Rizzieri, MD, and Thomas LeBlanc, MD, recently discussed the benefits of therapy for the great majority of older acute myeloid leukemia patients, the factors influencing the determination of appropriate treatment, and the expanded treatment options provided by numerous targeted therapies and less intensive chemotherapies that combine for durable remissions, improved quality of life, and highly individualized treatment plans.